Endoscopic Vessel Harvesting Systems Market Size - By Product Type (EVH Systems, Endoscopes), Usability (Disposable, Reusable), Technique, Vessel Type (Saphenous Vein), Application (Coronary Artery, Peripheral Artery), End-Use & Forecast, 2024 – 2032

Endoscopic Vessel Harvesting Systems Market Size

Endoscopic Vessel Harvesting Systems Market size was valued at USD 549.7 million in 2023 and is expected to grow at a CAGR of 4.2% between 2024 and 2032, propelled by the increasing prevalence of cardiovascular diseases and a growing preference for minimally invasive surgical techniques.
 

The increasing prevalence of cardiovascular diseases presents a significant global health concern, attributed to factors such as the aging population, lifestyle modifications, and the overall burden of cardiovascular conditions. Rising incidence of conditions such as peripheral vascular disease (PVD) and coronary artery disease (CAD), necessitating minimally invasive surgery procedures.
 

According to the Centers for Disease Control and Prevention (CDC), approximately 695,000 individuals in the U.S. died from heart disease in 2021, accounting for 1 in every 5 deaths, with 375,476 deaths attributed to coronary heart disease alone. These findings highlight the evolving landscape of CAD, PVD, and related conditions worldwide, focusing on the importance of ongoing surveillance and preventive interventions, such as endoscopic vessel harvesting systems, in addressing cardiovascular health.
 

Endoscopic vessel harvesting (EVH) systems are specialized medical devices used in cardiac surgery to extract blood vessels such as the saphenous vein or radial artery for use as grafts in surgical procedures. These systems employ endoscopic technology, including cameras and long, thin instruments, to visualize and dissect blood vessels through small incisions or punctures in the patient's body.
 

Endoscopic Vessel Harvesting Systems Market Trends

The latest technological advancements in EVH systems represent a significant step forward in improving the efficiency, precision, and safety of the vessel harvesting process in cardiac surgery. These advancements ultimately translate into better outcomes for patients, with reduced postoperative complications and faster recovery times.
 

• The advancements in EVH technology aim to optimize conduit quality, reduce complications, enhance patient satisfaction, and improve clinical results in cardiovascular procedures. For instance, the development of Vasoview Hemopro 2 Endoscopic Vessel Harvesting System by Getinge represents the latest generation of simultaneous cut-and-seal technology for EVH. These devices virtually eliminate the thermal spread and ensure high-quality conduit acquisition for coronary artery bypass graft (CABG) procedures.
   
• Moreover, the advanced medical imaging technology in the EVH devices enabled the surgeons with improved visualization capabilities. For instance, the integration of near-infrared fluorescence imaging in EVH devices allows for real-time visualization of blood vessels during the harvesting process, enhancing precision and reducing the risk of damage to the vessels. These advancement in the EVH devices ensures better outcomes in coronary artery bypass grafting (CABG) procedures, thus supporting the market growth.
   

Endoscopic Vessel Harvesting Systems Market Analysis

The market by product type is categorized into EVH systems, endoscopes, and accessories. The EVH systems segment dominates the endoscopic vessel harvesting systems market with a revenue of around USD 302.8 million in 2023.
 

• The demand for EVH systems is driven by the clinical need for minimally invasive techniques in cardiac surgery, particularly for procedures like coronary artery bypass grafting (CABG). Endoscopic vessel harvesting is a critical step in CABG surgery, and EVH systems offer increased advantages compared to traditional open harvesting methods. This clinical need is anticipated to fuel the demand for EVH systems in the cardiac surgery setting. 
   
• Moreover, EVH systems are specifically designed for the harvesting of blood vessels in cardiac surgery, providing surgeons with dedicated tools and features tailored to this procedure. In contrast, endoscopes and accessories may have a broader range of applications across various medical specialties, making EVH systems more specialized and in-demand for their specific purpose.
   

The endoscopic vessel harvesting systems market by usability is categorized into reusable and disposable. The reusable segment dominates the market with a revenue of around USD 354.7 million in 2023.
 

• The cost for reusable EVH systems typically tends to be lower as they can be sterilized and reused multiple times. Healthcare facilities with high procedural volumes may find reusable systems more cost-effective in the long run, leading to greater demand for this segment.  
   
• Moreover, reusable EVH systems may offer greater flexibility and customization options which allows healthcare facilities to choose compatible instruments and accessories. This flexibility allows for greater efficiency and optimization of the vessel harvesting process, contributing to the demand for reusable systems.
   

The endoscopic vessel harvesting systems market by technique is categorized into open tunnel harvesting and closed tunnel harvesting. The closed tunnel harvesting segment dominates the market with a revenue of around USD 328.8 million in 2023.
 

• Studies have demonstrated reduced risks of wound infection, hematoma formation, and nerve injury with closed tunnel harvesting, contributing to its increasing adoption. The potential for fewer complications enhances the safety profile of closed tunnel harvesting and drives its demand among surgeons and healthcare facilities.
   
• Moreover, closed tunnel harvesting typically results in smaller incisions and less visible scarring. These improved cosmetic outcomes associated with closed tunnel harvesting appeal to patients, particularly those concerned about aesthetic considerations. Surgeons may also prefer closed tunnel harvesting for its ability to achieve better cosmesis, contributing to its increasing demand.

The endoscopic vessel harvesting systems market by vessel type is categorized into saphenous vein, radial artery, and internal mammary artery. The saphenous vein segment held a majority market share and was valued at around USD 304 million in 2023.
 

• The saphenous vein is one of the most commonly used conduits for CABG surgery, which involves bypassing blocked or narrowed coronary arteries to restore blood flow to the heart muscle. As CABG procedures remain a mainstay in the treatment of coronary artery disease, there is a consistent demand for saphenous vein harvesting systems.
   
• The saphenous vein is readily accessible and can be easily harvested from the patient's leg. Compared to other potential graft sources, the saphenous vein is often more accessible and can be harvested with fewer technical challenges. This ease of access contributes to the widespread use of saphenous vein systems in CABG surgery and drives the demand for harvesting systems specifically designed for this vessel type.
   

The endoscopic vessel harvesting systems market by application is categorized into coronary artery disease and peripheral artery disease. The coronary artery disease segment is anticipated to reach around USD 531 million by 2032.
 

• Increased healthcare spending and improved access to medical care have led to better detection, diagnosis, and management of CAD. Advances in medical technology and diagnostic techniques enable earlier detection of CAD, allowing for timely interventions to prevent disease progression and reduce complications.
   
• Additionally, CAD is one of the leading causes of deaths globally and has been on the rise due to certain lifestyle related factors. The aging population, in particular, contributes to a higher prevalence of CAD, as the risk of developing the disease increases with age, and is contributing to the rising demand for endoscopic vessel harvesting systems for CAD applications.
   

The endoscopic vessel harvesting systems market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospital segment held a majority market share in with a revenue of around USD 325.4 million in 2023.
 

• Endoscopic vessel harvesting systems are primarily used in cardiac surgery, specifically for procedures like coronary artery bypass grafting (CABG). These surgeries are complex and require specialized equipment and expertise, which are typically found in hospital settings with dedicated cardiac surgery departments, making them most prominent end user for these devices.
   
• Moreover, cardiac surgery requires highly skilled and experienced surgical teams, including cardiothoracic surgeons, anesthesiologists, perfusionists, and operating room nurses. Hospitals employ specialized cardiac surgery teams with expertise in using EVH systems to perform complex procedures safely and effectively. Hence, they are the major facilities to utilize and incorporate these devices.

North America endoscopic vessel harvesting systems market accounted for USD 222.7 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America has a significant burden of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD). As such, there is a considerable demand for effective treatment options, including CABG surgeries where endoscopic vessel harvesting systems are utilized. Further, continuous advancements in endoscopic vessel harvesting systems, such as the development of minimally invasive techniques and robotic-assisted procedures, contribute to the demand for these systems in the region.
   
• Moreover, favorable reimbursement policies for minimally invasive surgical procedures, including EVH, incentivize healthcare providers to adopt these technologies. In North America, robust healthcare systems and adequate reimbursement for cardiac surgeries contribute to the widespread adoption of EVH systems in hospitals and surgical centers.
   

Endoscopic Vessel Harvesting Systems Market Share

The endoscopic vessel harvesting systems industry is consolidated in nature, with key large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are key market strategy, driving the competition and innovation in the endoscopic vessel harvesting systems industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced portable medical systems.
 

Endoscopic Vessel Harvesting Systems Market Companies

Some of the eminent market participants operating in the endoscopic vessel harvesting systems industry include:

• Cardio Precision Ltd.
• Getinge AB
• LivaNova PLC
• Medical Instruments Spa
• Saphena Medical Inc.
• Sorin Group
• Terumo Corporation
   

Endoscopic Vessel Harvesting Systems Industry News

• In March 2024, Getinge announced that it has received the U.S. FDA clearance for its Vasoview Hemopro 3, EVH system to be used in cardiovascular surgery. This approval may improve the company’s reputation and enable them with increased customer base in coming years.
   
• In September 2021, CardioPrecision launched its suite of CoreVista devices for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) procedures.
   

The endoscopic vessel harvesting systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• EVH systems
• Endoscopes
• Accessories

Market, By Usability

• Reusable
• Disposable

Market, By Technique

• Open tunnel harvesting
• Closed tunnel harvesting

Market, By Vessel Type

• Saphenous vein
• Radial artery
• Internal mammary artery

Market, By Application

• Coronary artery disease
• Peripheral artery disease

By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

 The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa